Astrazeneca gets marketing authorisation to use anti-diabetes drug for kidney disease February 8, 2021 Auto Bot News 0 The drug is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment of patients with CKD, it added.